American Chemical Society
np200441h_si_004.pdf (1.04 MB)

Proteasome Inhibitors from Neoboutonia melleri

Download (1.04 MB)
journal contribution
posted on 2016-02-22, 07:33 authored by Christophe Long, Joséphine Beck, Frédéric Cantagrel, Laurence Marcourt, Laure Vendier, Bruno David, Fabien Plisson, Fadila Derguini, Isabelle Vandenberghe, Yannick Aussagues, Frédéric Ausseil, Catherine Lavaud, François Sautel, Georges Massiot
Thirty new cycloartane derivatives (13, 512, 1432) have been isolated from the leaves of Neoboutonia melleri. Their novelty stems from the loss of one of the C-4 methyl groups (13, 512, 1425, and 32) and from the presence of an “extra” carbon atom in the side chain (13, 512, 1420, 2629, and 3032). Furthermore, compound 32 possesses a rare triterpene skeleton with the cyclopropane ring fused onto C-1 and C-10, instead of C-9 and C-10. The structures were determined by spectrometric means, chemical correlations, and X-ray crystallography of derivative 1c. The substitution pattern in ring A, with a cyclopropyl ring conjugated with an α,β-unsaturated carbonyl moiety, confers to the molecule a particular reactivity, giving rise to a formal inversion of the stereochemistry of the cyclopropane ring under UV irradiation. These compounds showed an interesting level of activity on the proteasome pathway, thus motivating their evaluation as possible anticancer agents. The large number of isolated compounds permitted a structure–activity relationship analysis, which showed that the presence of the two enone functions was a requirement for the activity.


Usage metrics

    Journal of Natural Products


    Ref. manager